Arrowstreet Capital’s Upstream Bio UPB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1M Sell
189,832
-167,924
-47% -$1.1M ﹤0.01% 1557
2026
Q2
$2.48M Buy
357,756
+172,669
+93% +$1.45M ﹤0.01% 1481
2026
Q1
$1.67M Buy
+185,087
New +$3.33M ﹤0.01% 1442

Other funds holding UPB

Arrowstreet Capital's UPB Position: Q3 2026 in Review

Arrowstreet Capital reduced its Upstream Bio (UPB) stake by 47% in Q3 2026, selling an estimated $1.1M and leaving 189,832 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1557.

Arrowstreet Capital first reported a position in UPB in Q1 2026 and has held it in 3 quarters since. The position peaked at $2.48M in Q2 2026. 133 funds tracked by Wall St. Rank hold UPB as of Q3 2026.

  • Arrowstreet Capital held 189,832 shares of Upstream Bio worth $1M as of Q3 2026.
  • Arrowstreet Capital sold 167,924 Upstream Bio shares in Q3 2026, an estimated $1.1M.
  • Upstream Bio made up ﹤0.01% of Arrowstreet Capital's portfolio in Q3 2026, its #1557 holding.
  • Arrowstreet Capital first reported a position in Upstream Bio in Q1 2026 and has held it in 3 quarters since.
  • Arrowstreet Capital's Upstream Bio position peaked at $2.48M in Q2 2026.
  • 133 funds tracked by Wall St. Rank held Upstream Bio as of Q3 2026.

Based on Arrowstreet Capital's 13F filing for Q3 2026, filed 13 Nov 2026.